Member Companies to Phase Out Use of Medically Important Antibiotic Products for Growth Promotion March 10, 2014 — Members of the Animal Health Institute (AHI) and the Generic Animal Drug Alliance (GADA) today announced their written commitments to align all affected products with the Food and Drug Administration’s (FDA) policy on judicious use of antibiotics. [...]
AHI members in the biologics industry continue to invest millions of dollars in the development of effective vaccines to advance the control and eradication of zoonotic disease in animals. Working closely with the USDA Center for Veterinary Biologics (CVB) these vaccines are licensed and made available to the animal health industry.
Learn how AHI member companies are advancing research in animal vaccines.